WITN0644100 - Risk reduction strategies for variant Creutzfeldt Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders
Article titled Risk reduction strategies for variant Creutzfeldt Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders CM Millar et al
Documents
WITN0644100 Risk reduction strategies for variant Creutzfeldt Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders